Article

Russell Cohen, MD, Discusses Medication Adherence in Inflammatory Bowel Disease

Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines."

Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines." There have been many breakthroughs in medication adherence for managing IBD. For instance, Dr Cohen says once-a-day dosing ensures patients don't fall behind in taking their prescribed medications.

This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.

Related Videos
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Lynae Darbes, PhD
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo